Merozan Special Precautions

Patients who had experienced hypersensitivity reactions to carbapenems, penicillins or other beta-lactam antibiotics may demonstrate hypersensitivity to meropenem as well. As with all beta-lactam antibiotics, rare hypersensitivity reactions have been reported (See Adverse Reactions). As with other antibiotics, overgrowth of non-susceptible organisms may occur and, therefore, continuous monitoring of each patient is necessary.
Use in infections caused by methicillin resistant staphylococci is not recommended. Rarely, pseudomembranous colitis has been reported on meropenem as with practically all antibiotics. Therefore, it is important to consider the diagnosis of pseudomembranous colitis in the case of patients who develop diarrhoea in association with the use of Meropenem (Merozan).
The co-administration of Meropenem (Merozan) with potentially nephrotoxic drugs should be considered with caution. For dosage see Dosage & Administration.
Use in Children: Efficacy and tolerability in infants under 3 months old have not been established; therefore, Meropenem (Merozan) is not recommended for use below this age.
Effects on ability to drive and use machines: No data are available, but it is not anticipated that Meropenem (Merozan) will affect the ability to drive and use machines.